Introduction
Resistant hypertension (RH) is defined as blood pressures (BP) uncontrolled on ≥3 or controlled on ≥4 different classes of antihypertensive medications at optimal doses and preferably including a diuretic.
• Insulin resistance and obstructive sleep apnea are two common associations of RH.
• True RH and pseudo-RH are two subsets of RH which have to be identified and treated.
BP measurement artifacts
• It is important to obtain accurate BP values before labeling as RH. Standard BP measurement protocols are required to segregate true RH from apparent RH.
• To minimize measurement artifacts.
• To get a BP value which represents true out-of-office BP.
• BP has to be measured accurately in office setting by trained individuals to avoid problem of white-coat effect.
• Automated office BP in which a series of BP measurements are made in office usually mimicks daytime recordings. [1] Optimal therapy
• It is important to define what is optimal therapy before classifying patients as true RH.
What medications and what dose ?
Patient should be on three different classes of antihypertensive medications including a diuretic. [2] Antihypertensive dose should be ≥50% of maximum recommended dose.
Patient adherence
Can be assessed by direct questions -Are you regularly taking medications?
• Indirect question: Regarding concern for cost or side effects.
• In apparent RH, clinicians appear to have opportunities to improve BP control by optimizing antihypertensive medication dosing.
• Once a diagnosis of true RH is made, one has to evaluate for the cause of secondary hypertension (HTN).
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• Many RH patients are volume expanded and respond to intensified diuretic therapy, sodium restriction, dual calcium-channel blocker, or α-adrenoreceptor blocker. Plasma renin activity can be used for personalized therapy in RH. 
Prognosis
In patients with apparent-resistant HTN based on the measurement of office BP, the subject with nonhypertensive out-of-office BP values has a favorable prognosis. This is where ambulatory BP recordings are useful. Both self-monitored BP and ambulatory BP recordings provide prognostically important information beyond office BP, in this group of patients.
[1]
Pharmacotherapy of RH
Commonly prescribed three drugs regimen for RH include ARB + CCB + thiazide diuretic. Beta blockers could be added for specific indications. Eplerenone is an alternative aldosterone antagonist devoid of sex steroid effects.
Beta Blockers
Aldosterone is projected to play a major role in BP regulation in long term than renin-angiotensin system. [5] Aldosterone raises BP by increasing number and activity of epithelial sodium channels. Amiloride which is epithelial sodium channel blocker has similar effect as Aldosterone antagonist.
However target organ protection is seen only with Aldosterone antagonist Patients with serum K+ value >4.5 and eGFR <45 ml/min are not ideal candidates for spironolactone. Target organ protection is a major advantage of Aldosterone antagonists.
Diuretics
Escalating diuretic potency from hydrochlorothiazide to chlorthalidone to torsemide as GFR decline from >45 to <30 ml/1.7 m 2 /min helps to reduce fluid retention and helps in BP control. Personalized drug therapy depending on PRA may be a choice for truly RH.
Device-based therapy may evolve in future for the treatment of RH.
